Literature DB >> 31909851

Is neoadjuvant chemoradiotherapy sufficient in patients with advanced rectal malignancy and positive extra-mesorectal lateral lymph nodes?

N Ahmadi1,2, K G M Brown1,3, P Lee1,2, M Quinn2, K K S Austin1,2, M J Solomon1,2,3,4.   

Abstract

AIM: There is current debate about the optimal management of lateral pelvic lymph nodes (LPLNs) in rectal cancer between Western and Eastern centres. This paper aims to report the rate of histologically proven positive LPLNs in a group of patients undergoing the conventional Western approach to primary and recurrent rectal cancer.
METHOD: A retrospective cohort review of all patients who underwent LPLN dissection at Royal Prince Alfred Hospital in Sydney, Australia. This included patients who underwent pelvic exenteration who had LPLNs excised either en bloc for laterally invasive or recurrent tumours or as part of selective node dissection for suspicious lymph nodes on preoperative imaging. Histopathological results for these patients were compared with node status at preoperative imaging.
RESULTS: Seventy-one patients satisfied the inclusion criteria. Of those patients with positive nodes on histology, 27% (9/33) with radiologically positive LPLNs were treated with preoperative radiotherapy and 75% (9/12) with radiologically positive LPLNs were not treated with preoperative radiotherapy (P = 0.004). None of the 12 patients with radiologically negative nodes treated with radiotherapy had positive nodes; 25% (3/12) of the patients with radiologically negative nodes who were not treated with radiotherapy had positive nodes. Fifty-three per cent of patients developed postoperative complications.
CONCLUSION: Our study suggests that in patients with radiologically positive LPLNs chemoradiotherapy may not be enough to sterilize these extra-mesorectal lymph nodes as a large proportion (27%) will have residual viable adenocarcinoma cells. In patients with radiologically negative LPLNs, however, the addition of chemoradiotherapy may serve to adequately sterilize these lymph nodes without the need for prophylactic LPLN dissection. Colorectal Disease
© 2020 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Lateral pelvic lymph node; rectal cancer

Mesh:

Year:  2020        PMID: 31909851     DOI: 10.1111/codi.14950

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  2 in total

1.  Long-term Outcomes of Lower Rectal Cancer Patients Treated with Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection after Preoperative Radiotherapy or Chemoradiotherapy.

Authors:  Wataru Sakamoto; Shinji Ohki; Hisashi Onozawa; Hirokazu Okayama; Hisahito Endo; Shotaro Fujita; Motonobu Saito; Zenichiro Saze; Tomoyuki Momma; Seiichi Takenoshita; Koji Kono
Journal:  J Anus Rectum Colon       Date:  2021-04-28

2.  Management of Clinically Involved Lateral Lymph Node Metastasis in Locally Advanced Rectal Cancer: A Radiation Dose Escalation Study.

Authors:  Xiaolin Pang; Liang Huang; Yan Ma; Zhanzhen Liu; Peiyi Xie; Hailing Liu; Xiangbo Wan; Shuai Liu; Jian Zheng
Journal:  Front Oncol       Date:  2021-07-16       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.